According to Future Market Insights research, during the projected period, the Global animal antimicrobials and antibiotics market is expected to grow at a CAGR of 4.9%. The market value is projected to increase to US$ 7,878.2 million by 2033.
Demand for animal antimicrobials and antibiotics is expected to rise as a result of the widespread use of various types of meat and milk in dairy products, notably in the western diet, and the rapid spread of similar eating habits worldwide.
| Attribute | Details |
|---|---|
| Animal Antimicrobials and Antibiotics Market Size Value in 2023 | US$ 4,911.9 million |
| Animal Antimicrobials and Antibiotics Market Forecast Value in 2033 | US$ 7,878.2 million |
| Global Animal Antimicrobials and Antibiotics Market Growth Rate (2023 to 2033) | 4.9% |
The market is growing due to factors like the rise in zoonotic illnesses, the demand for animal-derived food products, and the adoption of regulations to curb the spread of animal diseases. Due to rising demand for pet insurance and rising expenditures for veterinary care, this market share for animal antimicrobials and antibiotics is predicted to grow.
During the forecast period, animal antimicrobials and antibiotics market participants can anticipate tremendous development potential due to the untapped emerging markets of China, India, and Brazil, as well as the rise in the overall population of companion animals.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Sales of animal antimicrobials and antibiotics are soaring as a result of the leading companies' new medication innovations and enhanced research and development facilities, which are fueling the demand for effective treatment of animal diseases.
It is anticipated that increasing numbers of people own companion animals and are willing to spend money to ensure their health and welfare. This is likely to support the expansion of the animal health industry, which then fuels the demand for animal antimicrobials and antibiotics.
The development of early warning systems for the majority of animal diseases by a number of government and non-government groups has fueled the expansion of the global market for animal antibiotics and antimicrobials.
Strict regulatory requirements and rising use of antibiotic substitutes like feed enzymes and probiotics are some of the reasons partially limiting the growth of the global market for animal antibiotics and antimicrobials.
Human infections that are resistant to antibiotics can lengthen sickness times, increase hospital admissions, and treatment failures that are fatal. Nearly 400,000 people per year die from food-borne illnesses, with children under the age of five accounting for over one-third of these deaths, according to the WHO.
Therefore, veterinarians advise treating animals with less potent antibiotics. These actions could have a big impact on how frequently antibiotics are used worldwide.
In addition to organizing listening sessions across the nation to hear the concerns of both producers and veterinarians, FDA has been working closely with the American Veterinary Medical Association, other veterinary associations, and groups that represent animal producers.
Based on our outreach, they are convinced that veterinarians and animal producers are aware of their responsibility in ensuring the proper and prudent administration of the animal antimicrobials and antibiotics.
Medically significant animal antimicrobials and antibiotics can no longer be used for production if manufacturers voluntarily adopt these changes; instead, they must be ordered or prescribed by a qualified veterinarian in order to continue treating, controlling, or preventing disease in food animals.
FDA is presently investigating methods for strengthening current data gathering efforts in partnership with other agencies, such as USDA and CDC. FDA expects to seek additional public feedback, as it creates these improvements in animal antimicrobials and antibiotics.
The USA, European, and Japanese regulatory agencies are brought together by the Veterinary International Committee for Harmonization (VICH), which also harmonizes the rules and technical specifications for registering veterinary products.
Principal Consultant
Geographically, North America dominates the market for animal antibiotics and antimicrobials, owing to the region's high prevalence of animal disease outbreaks, excessive consumption of livestock products, prevalence of pet ownership, and elevated awareness of animal disease outbreaks.
The leading market participants in North America are also making significant financial investments in the creation of medicines to treat animal ailments, prompting the demand for animal antimicrobials and antibiotics.
On a global scale, the market for animal antibiotics and antimicrobials is expanding at the quickest rate in Asia Pacific. The region's rapid expansion is related to the rise in the number of animals, the demand for animal antibiotics, and the prevalence of animal diseases.
Additionally, the market for animal antibiotics and antimicrobials in the Asia Pacific region is expanding as a result of rising disposable income, a rise in the number of people owning pets as companions, and a rise in government involvement in the fight against the spread of animal diseases in developing nations such as India and China.
Asian nations are predicted to experience the highest growth in the demand for livestock products like beef, milk, mutton, pork, and poultry products, according to a 2018 FAO (Food and Agriculture Organization of the United Nations) survey on mapping the supply and demand for food sourced from animals.
An important development in the market for animal antibiotics and antimicrobials is the strategic collaboration. In order to conduct research and produce cutting-edge animal antibiotics and antimicrobials, companies are forming strategic alliances with key industry players.
Recent Developments in the Market
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million for Value and Units for Volume |
| Key Regions Covered |
|
| Key Countries Covered |
|
| Key Segments Covered |
|
| Key Companies Profiled |
|
| Report Coverage | Market Forecast, Company Share Analysis, Competitive Landscape, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
| Customization & Pricing | Available upon Request |
The market is valued at US$ 4,911.9 million in 2023.
The leading companies in the market are Zoetis, Merck, and Elanco.
The food industry is the primary consumer of the market.
The market is estimated to reach US$ 7,878.2 million by 2033.
The market is expected to record a CAGR of 4.9% by 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (MT) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (MT) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Product Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Product Type, 2023 to 2033 5.3.1. Tetracyclines 5.3.2. Penicillins 5.3.3. Sulfonamides 5.3.4. Macrolides 5.3.5. Aminoglycosides 5.3.6. Lincosamides 5.3.7. Fluoroquinolones 5.3.8. Cephalosporins 5.3.9. Others 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Animal Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Animal Type, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Animal Type, 2023 to 2033 6.3.1. Companion Animals 6.3.2. Food Producing Animals 6.4. Y-o-Y Growth Trend Analysis By Animal Type, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Animal Type, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Mode of Delivery 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Mode of Delivery, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Mode of Delivery, 2023 to 2033 7.3.1. Premixes 7.3.2. Oral Powder 7.3.3. Oral Solution 7.3.4. Injection 7.4. Y-o-Y Growth Trend Analysis By Mode of Delivery, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Mode of Delivery, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) & Volume (MT) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) & Volume (MT) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. The USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Animal Type 9.2.4. By Mode of Delivery 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Animal Type 9.3.4. By Mode of Delivery 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Animal Type 10.2.4. By Mode of Delivery 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Animal Type 10.3.4. By Mode of Delivery 10.4. Key Takeaways 11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United Kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Animal Type 11.2.4. By Mode of Delivery 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Animal Type 11.3.4. By Mode of Delivery 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Animal Type 12.2.4. By Mode of Delivery 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Animal Type 12.3.4. By Mode of Delivery 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Animal Type 13.2.4. By Mode of Delivery 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Animal Type 13.3.4. By Mode of Delivery 13.4. Key Takeaways 14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Animal Type 14.2.4. By Mode of Delivery 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Animal Type 14.3.4. By Mode of Delivery 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) & Volume (MT) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) & Volume (MT) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Animal Type 15.2.4. By Mode of Delivery 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Animal Type 15.3.4. By Mode of Delivery 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Product Type 16.1.2.2. By Animal Type 16.1.2.3. By Mode of Delivery 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Product Type 16.2.2.2. By Animal Type 16.2.2.3. By Mode of Delivery 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Product Type 16.3.2.2. By Animal Type 16.3.2.3. By Mode of Delivery 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Product Type 16.4.2.2. By Animal Type 16.4.2.3. By Mode of Delivery 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Product Type 16.5.2.2. By Animal Type 16.5.2.3. By Mode of Delivery 16.6. United Kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Product Type 16.6.2.2. By Animal Type 16.6.2.3. By Mode of Delivery 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Product Type 16.7.2.2. By Animal Type 16.7.2.3. By Mode of Delivery 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Product Type 16.8.2.2. By Animal Type 16.8.2.3. By Mode of Delivery 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Product Type 16.9.2.2. By Animal Type 16.9.2.3. By Mode of Delivery 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Product Type 16.10.2.2. By Animal Type 16.10.2.3. By Mode of Delivery 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Product Type 16.11.2.2. By Animal Type 16.11.2.3. By Mode of Delivery 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Product Type 16.12.2.2. By Animal Type 16.12.2.3. By Mode of Delivery 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Product Type 16.13.2.2. By Animal Type 16.13.2.3. By Mode of Delivery 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Product Type 16.14.2.2. By Animal Type 16.14.2.3. By Mode of Delivery 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Product Type 16.15.2.2. By Animal Type 16.15.2.3. By Mode of Delivery 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Product Type 16.16.2.2. By Animal Type 16.16.2.3. By Mode of Delivery 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Product Type 16.17.2.2. By Animal Type 16.17.2.3. By Mode of Delivery 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Product Type 16.18.2.2. By Animal Type 16.18.2.3. By Mode of Delivery 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Product Type 16.19.2.2. By Animal Type 16.19.2.3. By Mode of Delivery 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Product Type 16.20.2.2. By Animal Type 16.20.2.3. By Mode of Delivery 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Product Type 16.21.2.2. By Animal Type 16.21.2.3. By Mode of Delivery 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Product Type 16.22.2.2. By Animal Type 16.22.2.3. By Mode of Delivery 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Product Type 16.23.2.2. By Animal Type 16.23.2.3. By Mode of Delivery 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Animal Type 17.3.4. By Mode of Delivery 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Bayer AG 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.1.5.2. Product Strategy 18.1.1.5.3. Channel Strategy 18.1.2. BoehringerIngelheim GmbH 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.2.5.2. Product Strategy 18.1.2.5.3. Channel Strategy 18.1.3. CevaSanteAnimale 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.3.5.2. Product Strategy 18.1.3.5.3. Channel Strategy 18.1.4. Dechra Pharmaceuticals PLC 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.4.5.2. Product Strategy 18.1.4.5.3. Channel Strategy 18.1.5. Eli Lilly and Company 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.5.5.2. Product Strategy 18.1.5.5.3. Channel Strategy 18.1.6. Merck & Co., Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.6.5.2. Product Strategy 18.1.6.5.3. Channel Strategy 18.1.7. Sanofi 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.7.5.2. Product Strategy 18.1.7.5.3. Channel Strategy 18.1.8. Vetoquinol S.A. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.8.5.2. Product Strategy 18.1.8.5.3. Channel Strategy 18.1.9. Virbac 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.9.5.2. Product Strategy 18.1.9.5.3. Channel Strategy 18.1.10. Zoetis, Inc. 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.10.5.2. Product Strategy 18.1.10.5.3. Channel Strategy 18.1.11. Elanco Animal Health 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.11.5.2. Product Strategy 18.1.11.5.3. Channel Strategy 18.1.12. Phibro Animal Health 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.12.5.2. Product Strategy 18.1.12.5.3. Channel Strategy 18.1.13. Virbac 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.13.5.2. Product Strategy 18.1.13.5.3. Channel Strategy 18.1.14. Kyoritsu Seiyaku (Japan) 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 18.1.14.5.2. Product Strategy 18.1.14.5.3. Channel Strategy 18.1.15. Tianjin Ringpu 18.1.15.1. Overview 18.1.15.2. Product Portfolio 18.1.15.3. Profitability by Market Segments 18.1.15.4. Sales Footprint 18.1.15.5. Strategy Overview 18.1.15.5.1. Marketing Strategy 18.1.15.5.2. Product Strategy 18.1.15.5.3. Channel Strategy 18.1.16. HIPRA 18.1.16.1. Overview 18.1.16.2. Product Portfolio 18.1.16.3. Profitability by Market Segments 18.1.16.4. Sales Footprint 18.1.16.5. Strategy Overview 18.1.16.5.1. Marketing Strategy 18.1.16.5.2. Product Strategy 18.1.16.5.3. Channel Strategy 18.1.17. Zydus Animal Health 18.1.17.1. Overview 18.1.17.2. Product Portfolio 18.1.17.3. Profitability by Market Segments 18.1.17.4. Sales Footprint 18.1.17.5. Strategy Overview 18.1.17.5.1. Marketing Strategy 18.1.17.5.2. Product Strategy 18.1.17.5.3. Channel Strategy 18.1.18. Inovet 18.1.18.1. Overview 18.1.18.2. Product Portfolio 18.1.18.3. Profitability by Market Segments 18.1.18.4. Sales Footprint 18.1.18.5. Strategy Overview 18.1.18.5.1. Marketing Strategy 18.1.18.5.2. Product Strategy 18.1.18.5.3. Channel Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Food and Beverage Insights
View Reports
Animal Antimicrobials and Antibiotics Market
